Adeline Divoux, PhD

Postdoctoral Fellow 

Dr. Adeline Divoux is a scientist who specializes in the biology of adipose tissue, particularly in the human obesity field. She is currently a post-doctoral fellow at the Translational Research Institute for Metabolism and Diabetes (TRI-MD). Dr. Divoux is currently PI of a clinical protocol studying the influence of epigenetic mechanisms on the differentially repartition of adipose tissue (abdominal versus gluteal depot). Coupled with her basic experience, new and emerging tools and approaches (such as next-generation sequencing) available via her collaborators at the Sanford Burnham Prebys Medical Discovery Institute, she is at a great position to explore the epigenetic regulation of human adipose tissue.   

Dr. Divoux was born in Paris, France. She completed her master of Sciences at Pierre and Marie Curie University, Paris, France with specialization in Integrative biology and physiology. Her training in the field of obesity research started as a PhD student in Dr. Karine Clement’s laboratory in Paris, France. Dr. Divoux’s research focused on adipose tissue inflammation and remodeling, both occurring during obesity. She published intensively during these four years (see ref. 2-11) and acquired the specific techniques required for human adipose tissue manipulation. She also co-supervised the European project ADAPT (Adipokines as Drug Targets to Combat Adverse Effects of Excess Adipose Tissue). In 2010, she obtained financial support from the French organization “Fondation pour la Recherche Médicale” to finish her research in Paris.

Dr. Divoux expanded her research in an industrial environment to study the influence of hypocaloric diet with low glycemic index on satiety, inflammatory status and intestinal flora. As a result of this experience, she learned how to manage a project with constraints such as short timelines, stringent legislations and limited budgets.


Divoux A, Karastergiou K, Xie H, Guo W, Perera RJ, Fried SK, Smith SR. Identification of a novel lncRNA in gluteal adipose tissue and evidence for its positive effect on preadipocyte differentiation. Obesity, 2014 August

Karastergiou K, Fried SK, Xie H, Lee MJ, Divoux A, Rosencrantz MA, Chang RJ, Smith SR. Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. J Clin Endocrinol Metab. 2012 Nov

Divoux A, Moutel S, Poitou C, Lacasa D, Veyrie N, Aissat A, Arock M, Guerre-Millo M, Clément K. Mast cells in human adipose tissue: link with morbid obesity, inflammatory status and diabetes. J Clin Endocrinol Metab. 2012 Jun

Tordjman J, Divoux A, Prifti E, Poitou C, Pelloux V, Hugol D, Bouillot JL, Bedossa P, Guerre-Millo M, Clément K. Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity. Journal of hepatology. 2012 May

Tam C, Tordjman J, Divoux A, Baur LA, Clément K. Adipose tissue remodeling in children: the link between collagen deposition and age-related adipocyte growth. J Clin Endocrinol Metab. 2012 April

Divoux A and Clément K. Architecture and the extracellular matrix: the still unappreciated component of the adipose tissue. Obes rev. 2011 Mars

Divoux A, Tordjman J, Lacasa D, Veyrie N, Hugol D, Aissat A, Basdevant A, Guerre-Millo M, Poitou C, Zucker JD, BedossaP, Clément K. Fibrosis in human adipose tissue: composition, distribution and link with lipid metabolism and fat mass loss.  Diabetes. 2010 Aug

Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clément K. 2010. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2010 Jun

Keophiphath M, Rouault C, Divoux A, Clément K, Lacasa D. 2010. CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler Thromb Vasc Biol. 2010 Jan

Liu J, Divoux A, Sun J, Zhang J, Clément K, Glickman JN, Sukhova GK, Wolters PJ, Du J, Gorgun CZ, Doria A, Libby P, Blumberg RS, Kahn BB, Hotamisligil GS, Shi GP. 2009. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009 Aug

Divoux A, Poitou C, Faty A, Tordjman J, Hugol D, Aissat A, Keophiphath M, Henegar C, Commans S, Clément K. 2009. Role of serum amyloid a in adipocyte-macrophage cross talk and adipocyte cholesterol efflux. J Clin Endocrinol Metab. 2009 May

Poitou C, Divoux A, Clément K. La sérum amyloïde A : une apolipoprotéine majeure de l’inflammation. Sang Thrombose Vaisseaux. 2008 Sept